A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.
The study, led by Queen Mary University of London and Barts Health NHS Trust, is funded with £2m from a Medical Research Council and National Institute for Health Research partnership, and will be recruiting patients from centres in Cambridge, Edinburgh, Liverpool, London, Nottingham, Oxford and Sheffield. The trial is coordinated through the Clinical Trials Unit at the University of Sheffield.
Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.
Current treatments include drugs to reduce inflammation but these have varying results, and surgery is often needed to remove the affected part of the bowel. In extreme cases, after multiple operations over the years, patients may require a final operation to divert the bowel from the anus to an opening in the stomach, called a stoma, where stools are collected in a pouch.
‘We might be able to radically alter the course of the disease’
Chief investigator Professor James Lindsay from Queen Mary’s Blizard Institute and a consultant at Barts Health NHS Trust said: “Despite the introduction of new drugs, there are still many patients who don’t respond, or gradually lose response, to all available treatments. Although surgery with the formation of a stoma may be an option that allows patients to return to normal daily activities, it is not suitable in some and others may not want to consider this approach.
“We’re hoping that by completely resetting the patient’s immune system through a stem cell transplant, we might be able to radically alter the course of the disease. While it may not be a cure, it may allow some patients to finally respond to drugs which previously did not work.”
Helen Bartlett, a Crohn’s disease patient who had stem cell therapy at John Radcliffe Hospital, Oxford, said: “Living with Crohn’s is a daily struggle. You go to the toilet so often, you bleed a lot and it’s incredibly tiring. You also always need to be careful about where you go. I’ve had to get off trains before because there’s been no toilet, and I needed to go there and then.
“I’ve been in and out of hospital for the last twenty years, operation after operation, drug after drug, to try to beat this disease. It’s frustrating, it’s depressing and you just feel so low.
“When offered the stem cell transplant, it was a complete no brainer as I didn’t want to go through yet more failed operations. I cannot describe how much better I feel since the treatment. I still have problems and I’m always going to have problems, but I’m not in that constant pain.”
Giving patients a new immune system
Receive an email update when we add a new CROHNS DISEASE article.
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
- Infliximab biosimilar safe, effective for Crohn’s disease on December 10, 2018 at 2:13 pm
The biosimilar of infliximab, CT-P13, demonstrated equivalency in safety and efficacy for the treatment of Crohn’s disease, according to data published in Annals of Internal Medicine. “CT-P13 is a bio... […]
- Biosimilar CT-P13 Matches Infliximab in Crohn’s Disease on December 10, 2018 at 2:04 pm
The biosimilar CT-P13 (Inflectra) showed equivalent efficacy and safety to the anti-tumor necrosis factor (TNF) antibody infliximab (Remicade) in a French health insurance-based study of infliximab-na... […]
- Crohn's disease and pregnancy on December 10, 2018 at 1:04 pm
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current lis... […]
- Inflammatory Bowel Disease Raises Prostate Cancer Risk on December 10, 2018 at 9:15 am
Men with inflammatory bowel disease (IBD) — Crohn’s disease or ulcerative colitis (UC), for example — are at increased risk of developing prostate cancer, according to a study conducted at the Northwe... […]
- Crohn's Disease Diagnostic and Therapeutic Market: Segmented by Applications and Geography Trends, Growth and Forecasts 2023 on December 6, 2018 at 3:34 pm
The Crohn's Disease Diagnostic and Therapeutic Market Report assists the Industry experts, analysts and business decision makers to isolate the current market scenario, opportunities, upcoming market ... […]
- SNL Star Treats Crohn's Disease with Marijuana on December 6, 2018 at 7:13 am
Saturday Night Live cast member Pete Davidson has had a roller-coaster year. In June, it was announced that he was engaged to pop star Ariana Grande. By October, the engagement was off. Then he receiv... […]
- What Diet Is Best to Manage Crohn's Disease? This Study Aims to Find Out on December 5, 2018 at 11:45 am
An estimated 3 million adults in the United States have inflammatory bowel disease (IBD), including Crohn’s disease, according to the Centers for Disease Control and Prevention. Crohn’s is a chronic d... […]
- Kidney Failure Risk Greater in Patients With Crohn's Disease on December 5, 2018 at 3:05 am
Patients with Crohn's disease (CD) are at higher risk of end-stage renal disease (ESRD), investigators from South Korea reported. In a retrospective study using the National Health Insurance database ... […]
- 9 Things You Should Know About Crohn's Disease for IBD Awareness Week on December 3, 2018 at 2:01 am
For IBD Awareness Week, there are some things I’d like to share about living with Crohn’s disease. This is #MyIBD. 1. My illness does not define me, but it is very much a part of who I am. I am a moth... […]
via Bing News